Eversept Partners, LP Axogen, Inc. Transaction History

Eversept Partners, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $180,750 - $262,500	-5,000 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$24.4 - $40.25 $1.29 Million - $2.12 Million	-52,723 Reduced 91.34%	5,000 $183,000
Q4 2017 Nov 08, 2023	BUY	$18.5 - $28.6 $1.07 Million - $1.65 Million	57,723 New	57,723 $1.63 Billion
Q4 2017 Feb 12, 2018	BUY	$18.5 - $28.6 $1.07 Million - $1.65 Million	57,723	57,723 $1.63 Million

188

41.9M

86.4K

14.3K

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $1B
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.